Full-Time

Human Resources Systems Associate

Confirmed live in the last 24 hours

Schrödinger

Schrödinger

501-1,000 employees

Computational platform for biopharmaceutical research

Government & Public Sector
Enterprise Software
Biotechnology

Compensation Overview

$80k - $130kAnnually

Mid

New York, NY, USA

Hybrid position requiring in-office presence.

Category
Human Resources
People & HR
Requirements
  • At least three years of experience in HRIS and HR process and/or system improvements
  • Robust background in employee data and HR systems (UKG, HRsoft, Activpayroll, Greenhouse is a plus)
  • Experience working with international teams
  • Familiarity with HR systems implementation preferred
  • Background in US and/or Global payroll configuration is a plus
Responsibilities
  • Oversee our HR systems, including UKG, HRSoft, Culture Amp, and Greenhouse Onboarding
  • Manage business processes involving HRIS and other systems in line with controls and standards
  • Configure processes to support the global business, maintain workflows, and partner with other teams for any integrations with other systems
  • Lead HR data management and ensure data integrity through audits and process controls
  • Ensure delivery of timely and accurate reports, analyzing people data and supporting ad hoc requests (e.g., employee turnover, EEOC reporting, DEI reporting, etc.)
  • Gather feedback to continue evolving HR systems and processes
  • Contribute to the HRIS implementation project
  • Facilitate vendor relationships
  • Identify and review process impediments, propose specific solutions, and work with various internal and external teams to implement changes (e.g., IT, software vendors, HR, Legal)

Schrödinger provides a computational platform that aids in the research efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. Their platform offers advanced computational tools that help in drug discovery and development across various therapeutic areas. Schrödinger's products work by using sophisticated algorithms and simulations to predict how different compounds will interact, which can significantly speed up the research process. Unlike many competitors, Schrödinger not only licenses its software but also engages in collaborative research and drug discovery programs, allowing for a more integrated approach to scientific research. The company's goal is to enhance scientific research and development through its platform, ultimately leading to the discovery of new drugs and therapies.

Company Stage

IPO

Total Funding

$362.7M

Headquarters

New York City, New York

Founded

1990

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Schrödinger received a $10M grant to expand predictive toxicology tools, enhancing drug safety.
  • Collaborations with companies like Avicenna improve Schrödinger's drug discovery efficiency.
  • Schrödinger's platform enables rapid exploration of chemical space, reducing development time.

What critics are saying

  • The Recursion and Exscientia merger creates a strong competitor in AI-driven drug discovery.
  • Avicenna's independent expansion could lead to competitive tensions with Schrödinger.
  • Increasing drug discovery complexity may strain Schrödinger's resources and capabilities.

What makes Schrödinger unique

  • Schrödinger's platform supports diverse clients, including biopharmaceuticals and academic institutions globally.
  • The company invests heavily in science and talent to enhance its computational platform.
  • Schrödinger's drug discovery programs span a broad range of therapeutic areas.

Help us improve and share your feedback! Did you find this helpful?